Clonal hematopoiesis in frequent blood donors, immune microenvironment and bispecific antibody response in diffuse large B-cell lymphoma, and blinatumomab as part of early consolidation therapy in CD19-positive Ph-negative B-cell acute lymphoblastic lymphoma
In this week's episode we’ll learn about how frequent blood donation affects clonal hematopoiesis in older, male blood donors; the effect of immune microenvironment on response to bispecific antibodies in diffuse large B-cell lymphoma; and the feasibility of adding blinatumomab to early consolidation therapy in CD19-positive Ph-negative B-cell acute lymphoblastic lymphoma.
Featured Articles
Clonal Hematopoiesis Landscape in Frequent Blood Donors
Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody response
Upfront Blinatumomab Improves MRD…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.